Atherosclerotic Cardiovascular Disease Risk Equivelents
1 clinical trials · Condition
◉ Watch Atherosclerotic Cardiovascular Disease Risk Equivelents
| Record | Firm | Date |
|---|---|---|
| Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support (NCT04807400) | Novartis Pharmaceuticals | 2021-07-07 |
Track Atherosclerotic Cardiovascular Disease Risk Equivelents automatically
Every clearance here is in the API, with alerts when new ones post.